Next Article in Journal
Ceramide and Related Molecules in Viral Infections
Next Article in Special Issue
Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD
Previous Article in Journal
Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
Review

Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles

Honorary CNRS and UPMC Research Director, Founder of RevInterCell, a Scientific Consulting Service, 91400 Orsay, France
Academic Editors: Stefano Forte and Aurelio Lorico
Int. J. Mol. Sci. 2021, 22(11), 5674; https://doi.org/10.3390/ijms22115674
Received: 1 April 2021 / Revised: 5 May 2021 / Accepted: 13 May 2021 / Published: 26 May 2021
(This article belongs to the Special Issue The Role of Extracellular Vesicles in the Diagnosis of Cancer)
There exist many different human cancers, but regardless of the cancer type, an early diagnosis is a necessary condition for further optimal outcomes from the disease. Therefore, efficient specific and sensitive cancer biomarkers are urgently needed. This is especially true for the cancers depicting a silent progression, and those only diagnosed in an already metastatic state with a poor survival prognostic. After a rapid overview of the previous methods for cancer diagnosis, the outstanding characteristics of extracellular vesicles (EVs) will be presented, as new interesting candidates for early cancer diagnosis in human biofluid non-invasive liquid biopsy. The present review aims to give the state-of-the-art of the numerous searches of efficient EV-mediated cancer diagnosis. The corresponding literature quest was performed by means of an original approach, using a powerful Expernova Questel big data platform, which was specifically adapted for a literature search on EVs. The chosen collected scientific papers are presented in two parts, the first one drawing up a picture of the current general status of EV-mediated cancer diagnosis and the second one showing recent applications of such EV-mediated diagnosis for six important human-specific cancers, i.e., lung, breast, prostate, colorectal, ovary and pancreatic cancers. However, the promising perspective of finally succeeding in the worldwide quest for the much-needed early cancer diagnosis has to be moderated by the many remaining challenges left to solve before achieving the efficient clinical translation of the constantly increasing scientific knowledge. View Full-Text
Keywords: extracellular vesicles (exosomes; microvesicles; oncosomes; apoptotic bodies); specific human cancers (lung; breast; colorectal; prostate; ovary; pancreatic) extracellular vesicles (exosomes; microvesicles; oncosomes; apoptotic bodies); specific human cancers (lung; breast; colorectal; prostate; ovary; pancreatic)
MDPI and ACS Style

Tatischeff, I. Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles. Int. J. Mol. Sci. 2021, 22, 5674. https://doi.org/10.3390/ijms22115674

AMA Style

Tatischeff I. Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles. International Journal of Molecular Sciences. 2021; 22(11):5674. https://doi.org/10.3390/ijms22115674

Chicago/Turabian Style

Tatischeff, Irène. 2021. "Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles" International Journal of Molecular Sciences 22, no. 11: 5674. https://doi.org/10.3390/ijms22115674

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop